Analysts' Top 5 Price Targets of June 08, 26
Reading Time: 4 minutes
BrightSpring Health [US10950A1060] Goldman Sachs initiates coverage with "Buy" and a price target of $71 (25% upside potential) Goldman Sachs is optimistic about BrightSpring because the company benefits from a strong structural trend - healthcare services are increasingly shifting from expensive hospitals to more affordable home and community-based care. BrightSpring combines care services and pharmaceutical services into an integrated platform, enabling more services per patient and allowing for economies of scale. At the same time, the company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
